Abstract
Cell counting, cell cycle analysis and Western immunoblotting were used to examine the effects of non-apoptotic doses of a ceramide analogue, C2, and a synthetic arginine–glycine–aspartic acid (RGD)-containing peptide, RGD, in MCF-7 and T47D cells to determine whether activation of these signalling pathways could alter the mitogenic potential of insulin-like growth factor I (IGF-I). IGF-I alone increased total cell number in both cell lines, associated with a rise in the percentage of cells in the S-phase of the cell cycle and a co-incident increase in cyclin A production. Treatments alone had no effects on cell number or cyclin A production relative to controls. C2 inhibited IGF-I-induced mitogenesis in both lines, whereas RGD was only effective in the T47D line. Despite inhibition of cell proliferation, IGF-I stimulation of cells in S-phase and of cyclin A levels were unaffected; however, an IGF-I-induced increase in cyclin B1 levels was inhibited by 30%. Low-dose induction of integrin and ceramide signalling pathways causes cells to be blocked in S-phase, thereby inhibiting the normal cycle of events associated with the IGF-I-induced mitotic signal. Activating these pathways may not only restrict tumour growth by induction of apoptosis but they may also directly inhibit IGF-I-induced cell proliferation.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Baserga, R. & Rubin, R. (1993). Cell cycle and growth control. Critical reviews in cukaryotic gene expression, 3, 47–61.
De Leon, D., Bakker, B., Wilson, D. M., Lamson, G. & Rosenfeld, R. G. (1990). Insulin-like growth factor binding proteins in human breast cancer cells: relationship to hIGFBP-2 and hIGFBP-3. J Clin Endocrinol Metab, 71, 530–532.
Freedman, V. H. & Shin, S. (1974). Cellular tumorigenicity in nude mice: correlation with cell growth in semisolid medium. Cell, 3, 353–359.
Frisch, S. M. & Francis, H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol, 124, 619–626.
Giancotti, F. G. & Ruoslahti, E. (1990). Elevated levels of α5β1, fibronectin receptor suppress the transformed phenotype of CHO cells. Cell, 60, 849–859.
Gill, Z. P., Perks, C. M., Newcomb, P. V. & Holly, J. M. P. (1997a). Insulin-like growth factor binding protein-3 (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J Biol Chem, 272, 25602–25607.
Gill, Z. P., Perks, C. M., Newcomb, P. V. & Holly, J. M. P. (1997b). Growth factor modulation of cell survival in response to a physiological signal for apoptosis in MCF-7 and fibroblast (1BR3G) cell lines. J Endocrinol, 152, abstract P 104
Graña, X. & Reddy, E. P. (1995). Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin dependent kinase inhibitors (CKIs). Oncogene, 11, 211–219.
Han, E. K., Guadagno, T. M., Dalton, S. L. & Assoian, R. K. (1993). A cell cycle and mutational analysis of anchorage-independent growth: cell adhesion and TGF-β1 control/G1/S transit specifically. J Cell Biol, 122, 461–471.
Hayman, E. G., Pierschbacher, M. D. & Ruoslahti, E. (1985). Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol, 100, 1948–1954.
Ingber, D. E. (1990). Fibronectin controls capillary endothelial cell growth based on its ability to modulate cell shape. Proc Natl Acad Sci USA, 87, 3579–3583.
Knudson, K. A., Rao, P. E., Damsky, C. H. & Buck, C. A. (1981). Membrane glycoproteins involved in cell-substratum interactions. Proc Natl Acad Sci USA, 78, 6071–6075.
Macaulay, V. M. (1992). Insulin-like growth factors and cancer. Br J Cancer, 65, 311–320.
Obeid, L. M., Linardic, C. M., Karolak, L. A. & Hannun, Y. A. (1993). Programmed cell death induced by ceramide. Science, 259, 1769–1771.
Papa, V., Gliozzo, B., Clark, G. M., McGuire, W. L., Moore, D., Fujita-Yam Vigneri, R., Peyrat, J. P. & Bonneterre, J. (1993). Type I IGF receptor in human breast diseases. Breast Cancer Res Treat, 22, 59–67.
Perks, C. M., Norman, M. R., Newcomb, P. V. & Holly, J. M. P. (1997). The effect of RGD-containing peptides on the phosphorylation of focal adhesion kinase (FAK) in human breast cancer and fibroblast cell lines. J Endocrinol, 152, abstract P 105
Peyrat, J. P., Bonneterre, J., Hecquet, B., Vennin, P., Louchez, M. M., Fournier, C., Lefebure, J. & Demaile, A. (1993). Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. European J Cancer, 29, 492–497.
Quinn, K. A., Treston, A. M., Unsworth, E. J., Miller, M. J., Vos, M., Grimley, C. & Battey, J. (1996). Insulin-like growth factor expression in human cancer cell lines. J Biol Chem, 271, 11477–11483.
Ruoslahti, E. & Pierschbacher, M. D. (1987). New perspectives in cell adhesion. Science (Washington DC), 238, 491–497.
Ruoslahti, E. & Pierschbacher, M. D. (1987). New perspectives in cell adhesion. Science (Wash DC), 238, 491–497.
Sara, V. R. & Hall, K. (1990). Insulin-like growth factors and their binding proteins. Physiol Rev, 70, 591–614.
Tucker, R. W., Butterfield, C. E. & Folkman, J. (1981). Interaction of serum and cell spreading affects growth of neoplastic and nonneoplastic cells. J Supramol Struct, 15, 29–40.
Zhang, Z., Vuori, K., Reed, J. C. & Ruoslahti, E. (1995). The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA, 92, 6161–6165.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Perks, C., Gill, Z., Newcomb, P. et al. Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines. Br J Cancer 79, 701–706 (1999). https://doi.org/10.1038/sj.bjc.6690113
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690113
Keywords
This article is cited by
-
Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol
BMC Cancer (2008)
-
Prolactin acts as a potent survival factor for human breast cancer cell lines
British Journal of Cancer (2004)
-
Tyrosine kinase signalling in breast cancer: Insulin-like growth factors and their receptors in breast cancer
Breast Cancer Research (2000)